Covered recipient · General Payments record
ANIKA N MANSFIELD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$361.64
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.65 | 16 |
| Education | $68.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $90.49 | 5 |
| Astellas Pharma US Inc | $90.47 | 2 |
| Novo Nordisk AS | $57.23 | 3 |
| Acerta Pharma LLC | $50.33 | 3 |
| Abbott Laboratories | $20.58 | 1 |
| Phathom Pharmaceuticals, Inc. | $19.62 | 1 |
| Exact Sciences Corporation | $19.45 | 1 |
| Amgen Inc. | $13.47 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $361.64 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.58 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125106734 | CMS |
| ABBVIE INC. | $14.13 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107587261 | CMS |
| ABBVIE INC. | $16.18 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107587263 | CMS |
| ABBVIE INC. | $22.91 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107587265 | CMS |
| ABBVIE INC. | $17.62 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107587267 | CMS |
| ABBVIE INC. | $19.65 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107587269 | CMS |
| Amgen Inc. | $13.47 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117619320 | CMS |
| Astellas Pharma US Inc | $21.48 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139551073 | CMS |
| Astellas Pharma US Inc | $68.99 | 11/25/2024 | Education | Undisputed | 01/23/2026 | 1139541564 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.29 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104497674 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.20 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104318930 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.84 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104254187 | CMS |
| Exact Sciences Corporation | $19.45 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114535738 | CMS |
| Novo Nordisk Inc | $22.02 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100461034 | CMS |
| Novo Nordisk Inc | $18.64 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100455828 | CMS |
| Novo Nordisk Inc | $16.57 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100480117 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.62 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151185761 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.